Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Kyung Kyu Kim, M.D., Ja Kyung Kim, M.D., Do Young Kim, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Kyung Young Chung, M.D. and Kwang-Hyub Han, M.D.

Clin Mol Hepatol. 2005;11(4):350-358. Published online January 1, 1970

View: 2907 Download: 20

Difference in Early Postoperative Recurrence Rate of Hepatocellular Carcinoma According to the Imaging Modalities Used for Preoperative Staging : Comparison Between CTAP and CTHA, Lipiodol CT and Three Phase Helical CT

Moon Seok Choi, Seung Woon Paik, Sang Goo Lee, Joon Hyoek Lee, Kwang Cheol Koh, Poong Lyul Rhee, Jae Jun Kim, Jong Chul Rhee and Kyoo Wan Choi

Clin Mol Hepatol. 1998;4(4):358-364. Published online January 1, 2000

View: 1978 Download: 13

Usefulness of Combined CTAP and CTHA as a Preoperative Study of Hepatocellular Carcinoma

Suk Ho Lee , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Jong Kyun Lee , Kyu Taek Lee , In Koo Kang , Sung Yun Oh , Poong Lyul Rhee , Jae Jun Kim , Jong Chul Rhee

Clin Mol Hepatol. 1997;3(4):329-336.

View: 2392 Download: 17

Treatment outcome of the patients with small hepatoma ( ≤ 5 cm in diameter ) in relation to treatment modalities and underlying liver function

Kun Hoon Song , Kwang Hyub Han , Young Myung Moon , Chae Yoon Chon , Won Choi , Kwan Sik Lee , In Suh Park , Byong Ro Kim , Jong Tae Lee

Clin Mol Hepatol. 1996;2(2):186-197.

View: 65535 Download: 13

1 |

Viewed By 5509	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4695	MAFLD: How is it different from NAFLD?
Viewed By 4426	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3624	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3590	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search